How to Tell If Your Eyes Are Dry: Symptoms & Tests

Dry eyes can feel like more than just irritation. Learn the key symptoms, common triggers, and what a proper diagnosis actually looks like.

Dry eye disease shows up as a grab bag of sensations: stinging, grittiness, burning, blurred vision that clears when you blink, and sometimes, paradoxically, eyes that water nonstop. It affects somewhere between 5 and 50 percent of the population worldwide depending on the study and the diagnostic criteria used. The wide range hints at the core difficulty: figuring out whether your eyes are genuinely dry is trickier than it sounds, because symptoms alone can mislead you, and even clinical tests sometimes disagree with each other.

What Dry Eyes Actually Feel Like

The classic complaints are a sandy or gritty sensation, burning, stinging, redness, and a feeling of something stuck in your eye that isn’t there. Many people notice their vision gets temporarily blurry during tasks that demand sustained focus, like reading or driving, and then sharpens again after a few deliberate blinks. Sensitivity to light and wind is common, and so is discomfort that gets worse as the day goes on.

One symptom surprises nearly everyone who hears about it: excessive tearing. When the surface of the eye dries out and becomes irritated, the lacrimal gland can respond with a flood of watery “reflex” tears. These emergency tears are thin and lack the oily and mucus layers that keep normal tears from evaporating, so they spill over the lids without actually fixing the problem. If your eyes water constantly but still feel irritated, dryness is a plausible explanation, not a contradiction.

Why Symptoms and Tests Often Disagree

One of the most frustrating aspects of dry eye is what researchers call “discordance.” Some people have severe symptoms but look perfectly normal on examination. Others show obvious surface damage under a microscope yet report no discomfort at all. In studies of patients evaluated at specialty clinics, the correlation between standardized symptom scores and objective clinical signs has been negligible.

Research on Sjögren’s syndrome patients found essentially no significant correlations between individual ocular symptoms and the clinical signs measured during examination. A separate large study divided dry eye patients into “concordant” (symptoms matched exam findings) and “discordant” (symptoms present but normal exam) subgroups for analysis, confirming that the mismatch is common enough to deserve its own classification.

This disconnect matters for you because a normal eye exam does not rule out dry eye, and a single abnormal test result does not necessarily mean you have it. Clinicians generally rely on a combination of your reported symptoms and several different tests rather than any one measurement in isolation.

Screening Yourself With a Questionnaire

Before you ever sit in an exam chair, a validated self-assessment can help frame your symptoms. The most widely used is the Ocular Surface Disease Index, a twelve-item questionnaire that asks about how often you experience specific symptoms, how much they bother you during activities like reading or watching TV, and whether environmental triggers like wind or dry air make things worse. Your answers produce a score from 0 to 100, with higher numbers indicating more severe disease.

The OSDI has been shown to reliably discriminate between normal eyes, mild-to-moderate dry eye, and severe dry eye, matching both physician assessments and composite disease severity scores. It has also been validated across languages and populations. You can find the OSDI online and fill it out before your appointment. While it won’t replace a clinical evaluation, it gives your doctor a structured snapshot of how your eyes feel day-to-day and can help track whether treatment is working over time.

Tear Break-Up Time

Tear break-up time measures how quickly the thin film of tears on your eye starts to fall apart after a blink. In the traditional version, a drop of fluorescein dye is placed on the eye, and the doctor watches through a slit lamp with a blue light, counting the seconds until the first dark spot appears in the yellow-green tear film. A result under about ten seconds is considered abnormally fast and suggests the tear film is unstable.

Newer instruments can do this without dye by projecting a pattern of rings or a grid onto the tear surface and tracking how long it takes for the reflection to distort. These non-invasive methods tend to give somewhat different numbers than the traditional dye-based test. In one study of 65-year-olds, the first non-invasive break-up measurement averaged about 6 seconds while the fluorescein-based version averaged about 9 seconds, and there was no significant correlation between the two methods. Another study comparing several non-invasive devices found that all gave significantly different results from the fluorescein procedure.

The practical takeaway is that the specific number matters less than the trend. If your tear film is breaking up in two or three seconds consistently, that’s a clear problem regardless of the method. But borderline values need to be interpreted alongside everything else, because the technique, the device, and even the dye instillation itself can shift the number by several seconds.

The Schirmer Test and Tear Production

The Schirmer test is low-tech and has been around for over a century. A thin strip of filter paper is hooked over the lower eyelid and left in place for five minutes. The length of paper wetted by tears is measured in millimeters. Less than about 10 mm of wetting in five minutes suggests reduced tear production. The test can be done with or without a numbing drop; the version with anesthetic isolates “basal” tear secretion by preventing the reflex tearing that the paper strip itself provokes.

It sounds simple, but the Schirmer test is notoriously variable. Repeat the test on the same person ten minutes later and you can get a meaningfully different number. Environmental humidity affects it too: one study found that patients with moderate wetting lengths could be falsely diagnosed with dry eye simply because the test was performed in a low-humidity room. People with severe dry eye produced consistently low results regardless of humidity, but for milder cases the room conditions mattered enough to swing the result from normal to abnormal. This is one reason doctors rarely rely on the Schirmer test alone.

Surface Staining to Spot Damage

When tears are insufficient or unstable for a prolonged period, the cells on the surface of the eye start to suffer. Dye staining tests reveal this damage directly. Fluorescein highlights defects on the cornea under blue light, showing punctate dots where cells have been lost or are unhealthy. Lissamine green stains dead or damaged cells on the conjunctiva (the clear tissue covering the white of the eye) and is especially useful for detecting the kind of surface inflammation that accompanies dry eye disease.

In mild dry eye, staining tends to be limited to small patches in the exposed areas of the conjunctiva. As the disease progresses, it can spread across a wider area and eventually involve the cornea itself. The staining pattern gives the doctor a visual map of where and how badly the surface is affected. Using both dyes together can improve diagnostic accuracy, because each highlights slightly different types of damage. Research has confirmed that the two dyes give equivalent assessments of corneal severity, meaning lissamine green is a viable alternative in settings where it has historically been underused.

Meibomian Gland Imaging

Most dry eye is at least partly “evaporative,” meaning the oily outer layer of the tear film doesn’t hold up well enough to stop the watery layer underneath from evaporating. That oil comes from the meibomian glands, tiny glands embedded in the eyelids. When they become blocked, inflamed, or start to atrophy, the lipid layer thins out and tears evaporate too quickly. This condition, called meibomian gland dysfunction, is the leading contributor to dry eye complaints.

Meibography is an imaging technique that lets doctors look at the structure of these glands through the eyelid using infrared light. Healthy glands look like neat parallel columns. Diseased glands may appear shortened, tortuous, dilated, or missing entirely. In patients with visible gland dropout, the affected glands produced little to no oil. Newer software can quantify features like the total gland area, the degree of gland tortuosity, and shape irregularities, allowing doctors to grade gland loss objectively rather than by eyeballing it.

Meibography matters because gland loss is largely irreversible. If imaging shows you’ve lost a significant number of glands, the focus shifts to preserving the ones you have left through lid hygiene, warm compresses, and sometimes in-office treatments like thermal pulsation. Catching the problem early, before widespread dropout, gives you more options.

Point-of-Care Biomarker Tests

Two quick in-office tests measure biological markers associated with dry eye, and they offer information you can’t get from the tests described above.

Tear osmolarity measures how concentrated the salts in your tears are. The idea is straightforward: when tear production drops or tears evaporate too fast, what’s left becomes saltier. Normal tears sit around 300 mOsm/L; readings above about 308 mOsm/L suggest early dry eye, and values above 316 mOsm/L point toward moderate or severe disease. At a threshold of 308 mOsm/L, the test correctly identified severe dry eye about 91 percent of the time and normal eyes about 81 percent of the time. The catch is repeatability. The point-of-care devices used for osmolarity have shown poor repeatability in clinical conditions, meaning a single reading can be unreliable, and some studies have found that dry eye patients and healthy controls overlap substantially at the standard cutoffs. One study reported that roughly half of control subjects exceeded the 308 mOsm/L cutoff in at least one eye. So osmolarity is more useful for tracking trends over multiple visits than for making a one-time diagnosis.

The MMP-9 test (sold under the brand name InflammaDry) detects matrix metalloproteinase 9, an enzyme that spikes when the eye surface is inflamed. A small sample of tears is collected from the lower lid with a disposable applicator, and within about ten minutes, a colored line indicates whether MMP-9 levels are elevated. In a validation study, the test showed roughly 85 percent sensitivity and 94 percent specificity for dry eye-related inflammation, with a positive predictive value of 97 percent. Patients who tested positive also showed worse surface staining and higher overall disease severity. Where osmolarity tells you something about tear composition, MMP-9 tells you whether inflammation is driving the problem, which can change the treatment approach from simple lubrication toward anti-inflammatory therapy.

Conditions That Mimic Dry Eye

Not everything that feels like dry eye is dry eye. Allergic conjunctivitis causes itching, redness, and watering that overlap heavily with dry eye symptoms, though prominent itching and seasonal timing lean toward allergy. Blepharitis (inflammation of the eyelid margins) often coexists with dry eye and can be hard to separate. Medication side effects from antihistamines, antidepressants, and certain blood pressure drugs are common culprits too.

A less well-known mimic is corneal neuropathic pain, a condition where the nerves in the cornea become hypersensitive and send pain signals even when the ocular surface looks completely normal. Patients describe stinging, burning, light sensitivity, and a deep ache that seems out of proportion to any visible problem. Because their exams come back clean, their complaints are sometimes dismissed as psychological. A clue that neuropathic pain may be involved is that symptoms persist even after numbing drops are applied. Research has found that individuals whose ocular pain does not resolve with a topical anesthetic are more likely to show signs of central sensitization and report neuropathic-like symptoms. If artificial tears and standard dry eye treatments aren’t helping and your exam looks unremarkable, it’s worth raising this possibility with your eye care provider.

Screens, Environment, and Everyday Triggers

If your symptoms are worst at the end of a long workday, your environment is the first place to look. Staring at a screen sharply reduces how often and how completely you blink. Early research on office workers found the average blink rate dropped from about 22 blinks per minute at rest to around 7 while viewing text on a screen. A study of adolescents confirmed a dose-response pattern: those with the highest daily screen time had the lowest blink rates (averaging about 11 blinks per minute, compared to about 15 in the low-screen-time group) and significantly more dry-eye-type symptoms. On top of reduced blinking, a larger percentage of the blinks that do occur are incomplete, meaning the upper lid doesn’t fully sweep over the lower lid, leaving parts of the cornea exposed.

Temperature and humidity matter too. Lower temperatures and lower humidity have been linked to higher symptom scores, more surface staining, and elevated tear osmolarity in controlled studies. Laboratory measurements confirm that tear evaporation rates increase significantly when relative humidity drops. Air-conditioned offices, airplane cabins, and heated rooms in winter are all environments that accelerate evaporation. A small humidifier at your desk, positioning your monitor slightly below eye level so your lids cover more of the eye, and taking regular blink breaks are among the simplest things you can do before reaching for eye drops.

When Dry Eye Comes From Something Else

Dry eye isn’t always a standalone condition. It can be a secondary feature of systemic diseases, surgical procedures, or daily habits.

Sjögren’s syndrome, an autoimmune disease in which the immune system attacks moisture-producing glands, is one of the best-known medical causes. Patients with Sjögren’s-related dry eye tend to have more severe conjunctival staining and distinct biomarker patterns in their tears compared to people with ordinary dry eye, including reduced levels of a protective mucin and elevated levels of the inflammatory marker IL-8. Other autoimmune conditions, including rheumatoid arthritis and lupus, can produce similar effects. If dry eye appears alongside a persistently dry mouth, joint pain, or unexplained fatigue, it’s worth asking about autoimmune workup.

Refractive surgery is another common trigger. Virtually all patients who undergo LASIK develop some degree of dryness immediately afterward because the corneal nerves that drive reflex tear production are severed during the procedure. For most people this resolves within several months as nerves regenerate, but a fraction experience chronic dry eye that lasts well beyond the expected recovery window.

Cosmetics and the Tear Film

Eye makeup is rarely discussed in the context of dry eye, but research suggests it deserves attention. A study comparing women who regularly used eyeliner, mascara, or both against women who wore no eye makeup found that all makeup groups had significantly diminished tear film values. Meibography in the same study revealed greater meibomian gland loss in the makeup-wearing groups. The mechanism is probably multifactorial: particles from pencil eyeliner can migrate into the tear film within minutes of application, and chronic use may physically block gland openings. If you wear daily eye makeup and have unexplained dry eye symptoms, switching to products marketed as “ophthalmologist-tested” or taking periodic makeup-free days may be worth trying as part of a broader management strategy. Thorough but gentle removal at the end of the day is more important than the brand you choose, because residual makeup left on the lash line overnight has the longest contact time with the gland openings.

Two Main Types and Why Both Can Coexist

Clinicians traditionally split dry eye into two categories. Aqueous-deficient dry eye means the lacrimal glands don’t produce enough of the watery component. Evaporative dry eye means the tears that are produced evaporate too quickly, usually because of a weak lipid layer from meibomian gland dysfunction. In practice, the line between them is blurry: many patients have elements of both. There is also no consistent agreement in the literature on exactly which clinical characteristics define each subtype.

This matters for you because treatment depends on which mechanism dominates. If the issue is mostly evaporative, warm compresses and lid hygiene to get the meibomian glands flowing again are the first line. If it’s mostly aqueous-deficient, artificial tears, punctal plugs that slow tear drainage, or prescription secretagogues become more relevant. And if it’s a mix, you may need to address both fronts. A thorough workup that includes tear break-up time, surface staining, meibography, and possibly an inflammation marker test helps your doctor determine what’s driving your particular case so the treatment plan actually matches the problem.